Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 297, Issue 4, 2009, Pages

  Vessey, Donald A ^a,b   Li, Luyi ^a   Honbo, Norman ^a   Karliner, Joel S ^a,b,c  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardioprotection; Ischemia reperfusion injury; Preconditioning

Indexed keywords

5 (PARA SULFOPHENYL) THEOPHYLLINE; ADENOSINE RECEPTOR BLOCKING AGENT; G PROTEIN COUPLED RECEPTOR; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG;

ARTICLE; EX VIVO STUDY; HEART INFARCTION SIZE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HYPOXIA; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOSINE; ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; ISCHEMIC PRECONDITIONING, MYOCARDIAL; LYSOPHOSPHOLIPIDS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; MYOCYTES, CARDIAC; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LYSOSPHINGOLIPID; RECEPTORS, PURINERGIC P1; RECOVERY OF FUNCTION; SIGNAL TRANSDUCTION; SPHINGOSINE; THEOPHYLLINE; TIME FACTORS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 70349629000     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00358.2009     Document Type: Article

References (30)

1. 3H]phenylxanthine. Proc Natl Acad Sci USA 77: 5547-5551, 1980.
2. Buja LM, Entman ML. Modes of myocardial cell injury and cell death in ischemic heart disease. Circulation 98: 1355-1357, 1998. (Pubitemid 28462793)
3. Davis MD, Clemens JJ, Macdonald TL, Lynch KR. Sphingosine 1-phosphate analogs as receptor antagonists. J Biol Chem 280: 9833-9841, 2005.
4. Deutsch E, Berger EM, Kussmaul WG, Hirshfeld JW, Hermann HC, Laskey WK. Adaptation to ischemia during percutaneous transluminal coronary angioplasty: clinical hemodynamic, and metabolic features. Circulation 82: 2044-2051, 1990.
5. Goto M, Liu Y, Yang XM, Ardell JL, Cohen MW, Downey JM. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 77: 611-621, 1995.
6. Gross ER, Gross GJ. Ischemic preconditioning and myocardial infarction: an update and perspective. Drug Discov Today Dis Mech 4: 165-174, 2007. (Pubitemid 351966334)
7. Hansen PR. Myocardial reperfusion injury: experimental evidence and clinical relevance. Eur Heart J 16: 734-740, 1995.
8. Hausenloy DJ, Tsang A, Yellon DM. The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc Med 15: 69-75, 2004. (Pubitemid 40693390)
9. Jin ZQ, Zhou HZ, Zhu P, Honbo N, Mochly-Rosen D, Messing RO, Goetzl EJ, Karliner JS, Gray MO. Cardioprotection mediated by sphingosine- 1-phosphate and ganglioside GM-1 in wild-type and PKCε knockout mouse hearts. Am J Physiol Heart Circ Physiol 282: H1970-H1977, 2002. (Pubitemid 34663002)
10. Jin ZQ, Goetzl EJ, Karliner JS. Sphingosine kinase activation mediates ischemic preconditioning in murine hearts. Circulation 110: 1980-1989, 2004.
11. Jin ZQ, Zhang J, Huang Y, Hoover HE, Vessey DA, Karliner JS. A sphingosine kinase 1 mutation sensitizes the myocardium to ischemia/ reperfusion injury. Cardiovasc Res 76: 41-50, 2007. (Pubitemid 47362044)
12. Jin ZQ, Karliner JS, Vessey DA. Ischaemic postconditioning protects isolated mouse hearts against ischaemia/reperfusion injury via a sphingosine kinase isoform-1 activation. Cardiovasc Res 79: 134-140, 2008.
13. Karliner JS, Honbo N, Summers K, Gray MO, Goetzl EJ. The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes. J Mol Cell Cardiol 33: 1713-1717, 2001. (Pubitemid 32844228)
14. Kennedy S, Kane KA, Pyne NJ, Pyne S. Targeting sphingosine-1- phosphate signaling for cardioprotection. Curr Opin Pharmacol 9: 194-201, 2009.
15. Lecour S, Smith RM, Woodward B, Opie LH, Rochette L, Sack MN. Identification of a novel role for sphingolipid signaling in TNFa and ischemic preconditioning mediated cardioprotection. J Mol Cell Cardiol 34: 509-518, 2002.
16. Maxwell SR, Lip GY. Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options. Int J Cardiol 58: 95-117, 1997.
17. Means CK, Xiao CY, Li Z, Zhang T, Omens JH, Ishil I, Chun J, Brown JH. Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion. Am J Physiol Heart Circ Physiol 292: H2944-H2951, 2007. (Pubitemid 47084545)
18. 2A adenosine receptors attenuates the protective effects of myocardial postconditioning. Am J Physiol Heart Circ Physiol 293: H2523-H2529, 2007.
19. Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev 88: 581-609, 2008.
20. Murry CE, Richard VJ, Reimer KA, Jennings RB. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 66: 913-931, 1990.
21. Payne S, Milstein A, Spiegel S. Sphingosine-1-phosphate: dual messenger functions. FEBS Lett 531: 54-57, 2002.
22. Tao R, Zhang J, Vessey DA, Honbo N, Karliner JS. Deletion of the sphingosine kinase-I gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytes. Cardiovasc Res 74: 56-63, 2007. (Pubitemid 46366955)
23. Theilmeier G, Schmidt C, Herrmann J, Keul P, Schafers M, Hergott I, Mersmann J, Larmann J, Hermann S, Stypmann J, Schober O, Hildebrand R, Schulz R, Heusch G, Haude M, von Wnuck Lipinski K, Herzog C, Schmitz M, Erbel R, Chun J, Levkau B. High-density lipoproteins and their constituent, sphingosine-1- phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation 114: 1403-1409, 2006. (Pubitemid 44454560)
24. Vessey DA, Kelley M, Karliner JS. A rapid radioassay for sphingosine kinase. Anal Biochem 337: 136-142, 2005.
25. Vessey DA, Kelley M, Li L, Huang Y, Zhou H, Zhu BQ, Karliner JS. Role of sphingosine kinase activity in protection of heart against ischemia reperfusion injury. Med Sci Monit 12: BR318-BR324, 2006. (Pubitemid 44556077)
26. Vessey DA, Li L, Kelley M, Karliner JS. Combined sphingosine, S1P and ischemic postconditioning rescue the heart after protracted ischemia. Biochem Biophys Res Commun 375: 425-429, 2008.
27. Vessey DA, Li L, Kelley M, Karliner JS. Sphingosine can pre- and post-condition heart and utilizes a different mechanism from sphingosine 1-phosphate. J Biochem Mol Toxicol 22: 113-118, 2008. (Pubitemid 351657194)
28. Vessey DA, Li L, Kelley M, Huang Y. Sphingosine protects aging hearts from ischemia/reperfusion injury: superiority to sphingosine 1-phosphate and ischemic pre- and post-conditioning. Oxid Med Cell Longev 2: 146-151, 2009.
29. Zhang J, Honbo N, Goetzl EJ, Chatterjee K, Karliner JS, Gray MO. Signals from type 1 sphingosine 1-phosphate receptors enhance adult mouse cardiac myocyte survival during hypoxia. Am J Physiol Heart Circ Physiol 293: H3150-H3158, 2007. (Pubitemid 350106541)
30. Zhao ZQ, Vinten-Johansen J. Postconditioning: reduction of reperfusion- induced injury. Cardiovasc Res 70: 200-211, 2006.